Blog
Tim Dudderidge – Prostate Cancer UK Clinical Champion
In April 2021, 22 Health Care Professionals from across the UK became inaugural Clinical Champions for Prostate Cancer UK. The programme was established to create projects that aim to transform care for people living with or affected by prostate cancer over the next eighteen months. Twenty-two Clinical Champions were selected, and we’re delighted that Tim…
Read MoreInnovations in Prostate Cancer Treatment and Care – Tim Dudderidge Urologist
Urological Consultant Tim Dudderidge speaks to OnFocus about the innovations shaping the future of Prostate Cancer managment TFTC Urological Consultant Tim Dudderidge, based at University Hospital Southampton, joins OnFocus to discuss some of the new technologies that are coming through that we can expect to see impacting the experience and outcomes for men with prostate…
Read MoreProstate Cancer Side Effects, Incontinence, Impotence, Depression
In the many interviews and conversations we’ve had with our patients over the last year, few, if any, have concluded without mention of one or more of the “Big Three” side effects that accompany a prostate diagnosis and some forms of treatment – incontinence, sexual function and mental health. We talk about these all the…
Read MoreMen with Prostate Cancer are keen to maintain their sexual function, are their doctors listening?
From our conversations with almost 1,000 men who have approached the Focal Therapy Clinic about prostate cancer treatment, we know that many, if not most of them consider the preservation of their sexual function, sexual identity and sexual relationships second only to the preservation of life itself in considering their treatment options. They also tell…
Read MoreIn Remembrance of John Mallard
John Mallard’s passing last week has special significance to those of us pushing boundaries in imaging-led healthcare, and prostate cancer in particular. He pioneered the development of MRI for cancer detection, something that has literally revolutionised the diagnosis and treatment of prostate cancer. John Mallard was the first professor of medical physics at Aberdeen University,…
Read MoreHIFU Focal Therapy controls cancer as well as Radical Prostatectomy with no side effects: New Imperial College Study
We are pleased and proud that a landmark study led by Imperial College London comparing outcomes for men undergoing focal therapy and radical prostatectomy has been published this week, with considerable interest from the media. The Focal Therapy Clinic has played a significant role in this research through our clinicians and patient data. The study…
Read MoreThe Focal Therapy Clinic – Multidisciplinary Team Goes Digital
The multidisciplinary team (MDT) review of patient cases is indisputably a critical part of patient care for men with prostate cancer. Bringing urological, radiological, oncological and histological expertise together is in patients’ best interest and can significantly affect outcomes. Like many processes and procedures in healthcare, the MDT has had a push to go digital…
Read MoreRemember, Remember, The Month Of Movember
This week began the annual monthlong celebration of moustaches, raising of funds, and high-profile promotion of men’s health – also known as Movember. Founded in 2003 by JC Coghlin, Movember is a global community of “Mo Bros and Mo Sisters” making a difference in mental health and suicide prevention, prostate cancer and testicular cancer. Coghlin…
Read MoreAge discrimination could limit treatments offered to people with prostate cancer
This week saw a major investigation from The Times describing how the NHS overwhelmingly neglected and, worse, outright discriminated against older people during COVID. The Guardian weighed in, citing this as an amplification of something that has been happening for a while. Both reports generated widespread condemnation across many quarters, and stepped up advocacy amongst elderly and age support…
Read MoreProstate Cancer And The Black Community – The Beginning Of Progress?
As Black History Month draws to a close, it’s appropriate to focus on recent developments in understanding why black men in the UK bear twice the burden of prostate cancer as white men – 1 in 4 versus 1 in 8. Earlier this month, Jonathan Oloyede, leader of City Chapel in east London, joined OnFocus…
Read More